Showing 1331-1340 of 1395 results for "".
- Breakthrough Technology Used to Discover Eye Damage from Repeated Intravitreal Injectionshttps://modernod.com/news/breakthrough-technology-used-to-discover-eye-damage-from-repeated-intravitreal-injections/2477567/In a first of its kind study, Mount Sinai researchers are using optimal coherence tomography angiography (OCTA) to measure potential retina damage from long-term use of intravitreal eye injections. The findings, published in the April issue of Retina, suggest that repeated use of these i
- Contact Lens Institute Shares New CDC Guidance for Contact Lens Wear and COVID-19https://modernod.com/news/contact-lens-institute-shares-new-cdc-guidance-for-contact-lens-wear-and-covid-19/2477563/The Contact Lens Institute is sharing new guidance issued this week by the U.S. Centers for Disease Control and Prevention (CDC) regarding contact lens wear and care amid the COVID-19 pandemic. The direction,
- WSJ: Trump Administration Plans to Pay Hospitals to Treat Uninsured Coronavirus Patientshttps://modernod.com/news/wsj-trump-administration-plans-to-pay-hospitals-to-treat-uninsured-coronavirus-patients/2477529/The Trump administration is expected to use a federal stimulus package to pay hospitals that treat uninsured people with the new coronavirus as long as they agree not to bill the patients or issue unexpected charges, The Wall Street Journal
- FDA Approves Anti-Malarial Drugs Chloroquine And Hydroxychloroquine For Emergency Coronavirus Treatmenthttps://modernod.com/news/fda-approves-anti-malarial-drugs-chloroquine-and-hydroxychloroquine-for-emergency-coronavirus-treatment/2477496/The Food and Drug Administration on Sunday issued an emergency authorization for experimental coronavirus treatments using chloroquine and hydroxychloroquine, anti-malaria drugs touted by President Donald Trump despite inconclusive clinical proof of their effectiveness, according to a Forbes
- Abbott Launches Molecular Point-of-Care Test to Detect Novel Coronavirus in as Little as Five Minuteshttps://modernod.com/news/abbott-launches-molecular-point-of-care-test-to-detect-novel-coronavirus-in-as-little-as-five-minutes/2477479/Abbott announced that the FDA has issued Emergency Use Authorization (EUA) for the fastest available molecular point-of-care test for the detection of novel coronavirus (COVID-19), delivering positive results in as little as 5 minutes and negative results in 13 minutes, according to a company new
- Prevent Blindness Releases Message to Eye Care Patients Regarding the COVID-19 Pandemichttps://modernod.com/news/prevent-blindness-releases-message-to-eye-care-patients-regarding-the-covid-19-pandemic/2477470/In response to the numerous queries from patients and caregivers, Prevent Blindness has issued the following statement in regards to eye care during the coronavirus pandemic. “For everyone’s health and s
- COVID-19 Roundtable: How Retina Doctors From Around the United States Are Adjusting Their Clinicshttps://modernod.com/news/covid-19-roundtable-how-retina-doctors-from-around-the-united-states-are-adjusting-their-clinics/2477467/Eyewire News checked in with four retina specialists in COVID-19 hotspots around the United States—Seattle, New York, Boston, and Orlando—to see how they are adjusting their clinics in light of the AAO’s latest guidance. To read a full summary of their adjustments, read the forthcoming April issu
- CMS Recommends Limit on Nonessential Planned Surgeries, Including Postponement of Cataract Procedureshttps://modernod.com/news/cms-recommends-limit-on-nonessential-planned-surgeries-including-postponement-of-cataract-procedures/2477414/On March 18, CMS issued a series of recommendations regarding the furnishing of all nonessential planned surgeries and procedures based on the need to conserve critical resources, such as ventilators and personal protective equipment, and limiting exposure of patients and staff to COVID-19, accor
- Regeneron’s Novel COVID-19 Antibody Program Has Potential to Enter Human Clinical Studies by Early Summerhttps://modernod.com/news/regenerons-novel-covid-19-antibody-program-has-potential-to-enter-human-clinical-studies-by-early-summer/2477404/Regeneron Pharmaceuticals announced the latest progress in its efforts to discover and develop a novel multi-antibody cocktail that can be administered as prophylaxis before exposure to the SARS-CoV-2 virus or as treatment for those already infected. Regeneron scientists have now isolated
- AAO Provides Updated COVID-19 Guidance for Outpatient Clinics and Elective Surgeryhttps://modernod.com/news/aao-provides-updated-guidance-for-outpatient-clinics-and-elective-surgery/2477395/In response to the state of national emergency declared at the federal level, particularly as COVID-19 progresses in a given community, ophthalmologists should seriously consider both the intensity of clinic scheduling and the issue of elective surgeries, particularly in elderly patients and thos